GlassScriptPhysician profile
John L Briggs
NPI 1114276607
$404.69
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.37 · 2022: $370.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $205.80 | 2021-2022 | |
| Novo Nordisk INC | $46.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $39.78 | 2022 | |
| Abbott Laboratories | $21.54 | 2022 | |
| Nestle Healthcare Nutrition INC. | $19.14 | 2022 | |
| Amgen INC. | $16.26 | 2022 | |
| Esperion Therapeutics, INC. | $15.29 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.85 | 2021 | |
| Lilly USA, LLC | $11.69 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.